Stock Price Quote

DOLPHIN LABORATORIES LTD.

NSE : NABSE : 524578ISIN CODE : INE840C01017Industry : Pharmaceuticals & DrugsHouse : Private
BSE5.750 (0 %)
PREV CLOSE ( ) 5.75
OPEN PRICE ( ) 6.18
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )6.18 6.18
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 09-07 1951
Management Info
- Chairman Rajesh C Gandhi - Managing Director
Registered Office

Address 41,Sarat Bose Road, ,
Kolkata,
West Bengal-700020

Phone

Email --

Website NA

Registrars Details
Link Intime India Pvt Ltd.
(Formerly Mondkar Computers Pvt Ltd), 21 Shakil Niwas ,Opp. Satya Saibaba Temple, Mahakali Caves Road,Andheri (E),Mumbai
Listing : BSE

NEWS

No News Found

Financials

in Millions
QTR Jun 04 ANNUAL 03
Net Profit
Gross Profit
Operating Profit
Net Sales

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Neuland Laboratories (BSE)
peergroup  7519.90 (5.84%)
M.Cap ( in Cr)9647.95
NGL Fine-Chem (BSE)
peergroup  2264.35 (5.97%)
M.Cap ( in Cr)1398.92
Astrazeneca Pharma I (BSE)
peergroup  5288.60 (1.85%)
M.Cap ( in Cr)13221.50
Divi's Lab (BSE)
peergroup  3764.65 (1.32%)
M.Cap ( in Cr)99939.63
Dr. Reddy's Lab (BSE)
peergroup  6052.00 (0.70%)
M.Cap ( in Cr)100958.41

Shareholding Pattern

No Data Found

About Dolphin Laboratories Ltd.

Dolphin Laboratories Ltd. was incorporated in the year 1951. Its today's share price is 5.75. Its current market capitalisation stands at Rs 2.3 Cr. In the latest quarter, company has reported Gross Sales of Rs. 132.14 Cr and Total Income of Rs.135.27 Cr. The company's management includes Gyan Prakash Srivastava, Rajesh C Gandhi, Chandrakant I Gandhi, Chandrakant I Gandhi.

It is listed on the BSE with a BSE Code of 524578 , NSE with an NSE Symbol of and ISIN of INE840C01017. It's Registered office is at 41,Sarat Bose Road, Kolkata-700020, West Bengal. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Lodha & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.